• Contact
  • Login
  • Contact
  • Login
  • TTM2

  • Menu
  • Contact
  • Login
  • About the study
    • History
    • Who are we
  • News
  • Documents
  • Sites
  • Partners
  • Substudies

TTM2-trial soon to start

10 November 2017

After almost one year of planning we are delighted to announce that the TTM2-trial is soon ready to start in a selected group of vanguard sites. These sites will get the oportunity to give constructive feed back on instructions, trial infrastructure and protcol and will therefore pave the way for the main body of trial sites that will be initiated and start recruiting with the next quarter. Co-enrolment with the TAME-trial, additions of exiting and important sub-studies,  and the start up of a large biobank at the Integrated Biobank of Luxembourg will be inspiring projects within the TTM2-trial. Please take the oportunity to find additional trial material at this home page and look out for the news that the trial is launched.

News

Updated CRF

01 March 2018

New documents

28 February 2018

FOUR-score video

08 February 2018

Returning to work after cardiac arrest.

13 January 2018

Italy and screening instructions

10 January 2018

Wellington NZ first non-Swedish randomization

24 December 2017

Prognostication Checklist

18 December 2017

Vanguard sites and protocol update 1.1

05 December 2017

TTM2 has started!

20 November 2017

TTM2-trial soon to start

10 November 2017

Pages

  • « first
  • ‹ previous
  • 1
  • 2
  • 3
  • 4
  • next ›
  • last »

Helsingborg Hospital 
Anaesthesiology and Intensive Care 
Charlotte Yhlens gata 10
251 87 Helsingborg, Sweden
ttm2@ttm2trial.org

Skåne University Hospital
Center for Cardiac Arrest
Barngatan 2A, Practicum
22185 Lund, Sweden
ttm2@ttm2trial.org